In the meanwhile, radiotherapy can upregulate the expression of PD-L1 on tumor cells via IFN-γ released by CD8+ T cells and the PD-1 levels on CD8+ tumor infiltrating lymphocytes (TILs) (78, 82), which enhance the effect of PD-1 inhibitors. Here, PDCD1 is linked to neoplasm.